Targeting PD-1/PD-L1 interactions for cancer immunotherapy

被引：293
|
作者：
Zitvogel, Laurence [1 ,2 ,3 ,4 ]
Kroemer, Guido [3 ,5 ,6 ,7 ,8 ]
机构：
[1] Inst Gustave Roussy, INSERM, U1015, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Ctr Clin Invest CBT507, Villejuif, France
[3] Inst Gustave Roussy, Villejuif, France
[4] Univ Paris 11, Villejuif, France
[5] INSERM, U848, Villejuif, France
[6] Ctr Rech Cordeliers, Paris, France
[7] Hop Europeen Georges Pompidou, Paris, France
[8] Univ Paris 05, Fac Med, Paris, France
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 08期
关键词：
CELL CARCINOMA PATIENTS; CLINICAL-SIGNIFICANCE; PD-1; PATHWAY; B7-H1; EXPRESSION; MOLECULE; IMMUNOSUPPRESSION; RECEPTORS; LIGAND-1; ANTIBODY;
D O I：
10.4161/onci.21335
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1223 / 1225
页数：3
相关论文
共 50 条
  • [1] Divergent Expression of PD-1 as Challenges and Chances of Immunotherapy Targeting PD-1 or PD-L1 in Cancer
    Huang, Haozhe
    BIOINFORMATICS AND BIOMEDICAL ENGINEERING, PT II, IWBBIO 2024, 2024, 14849 : 55 - 69
  • [2] PD-1/PD-L1 and immunotherapy for pancreatic cancer
    Feng, Mengyu
    Xiong, Guangbing
    Cao, Zhe
    Yang, Gang
    Zheng, Suli
    Song, Xujun
    You, Lei
    Zheng, Lianfang
    Zhang, Taiping
    Zhao, Yupei
    CANCER LETTERS, 2017, 407 : 57 - 65
  • [3] Identifying Rational Candidates for Immunotherapy Targeting PD-1/PD-L1 in Cervical Cancer
    Kim, Miseon
    Kim, Hyojin
    Suh, Dong Hoon
    Kim, Kidong
    Kim, Haeryoung
    Kim, Yong Beom
    No, Jae Hong
    ANTICANCER RESEARCH, 2017, 37 (09) : 5087 - 5094
  • [4] Intelligent delivery system targeting PD-1/PD-L1 pathway for cancer immunotherapy
    Liu, Ning
    Zhang, Renshuai
    Shi, Qiang
    Jiang, Hongfei
    Zhou, Qihui
    BIOORGANIC CHEMISTRY, 2023, 136
  • [5] Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1
    Nagaraju, Ganji Purnachandra
    Malla, Rama Rao
    Basha, Riyaz
    Motofei, Ion G.
    SEMINARS IN CANCER BIOLOGY, 2022, 86 : 616 - 621
  • [6] Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy
    Lu, Jing
    Lee-Gabel, Linda
    Nadeau, Michelle C.
    Ferencz, Thomas M.
    Soefje, Scott A.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 21 (06) : 451 - 467
  • [7] Cancer immunotherapy and the PD-1/PD-L1 checkpoint pathway
    Barclay, Jonathan
    Creswell, Joanne
    Leon, Juan
    ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (04): : 393 - 399
  • [8] Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer
    Chen, Miaomiao
    Zhou, Yuli
    Bao, Kaicheng
    Chen, Siyu
    Song, Guoqing
    Wang, Siliang
    BIODRUGS, 2025,
  • [9] Targeting PD-1/PD-L1 in tumor immunotherapy: Mechanisms and interactions with host growth regulatory pathways
    Shen, Songyu
    Hong, Yihan
    Huang, Jiajun
    Qu, Xiaosheng
    Sooranna, Suren Rao
    Lu, Sheng
    Li, Tian
    Niu, Bing
    CYTOKINE & GROWTH FACTOR REVIEWS, 2024, 79 : 16 - 28
  • [10] PD-L1/PD-1 blockade in breast cancer: The immunotherapy era
    Li, Chia-Jung
    Lin, Li-Te
    Hou, Ming-Feng
    Chu, Pei-Yi
    ONCOLOGY REPORTS, 2021, 45 (01) : 5 - 12
12345